In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp

International Journal of Food Sciences and Nutrition

Volumn 66, Issue 8, 2015, Pages 919-922

  Li, Zhaoping ^a,b,c   Summanen, Paula H ^a   Komoriya, Tomoe ^a,d   Finegold, Sydney M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NIHON UNIVERSITY   (Japan)

Author keywords

Bifidobacterium; Lactobacillus; Prebiotic; Xylooligosaccharide

Indexed keywords

BACTERIAL RNA; GLUCURONIC ACID; OLIGOSACCHARIDE; PREBIOTIC AGENT; RNA 16S; XYLOOLIGOSACCHARIDE;

BIFIDOBACTERIUM; CLASSIFICATION; DRUG EFFECTS; GENETICS; LACTOBACILLUS; SEQUENCE ANALYSIS;

BIFIDOBACTERIUM; GLUCURONATES; LACTOBACILLUS; OLIGOSACCHARIDES; PREBIOTICS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, RNA;

EID: 84959332911     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2015.1064869     Document Type: Article

References (14)

1. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. 2009. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One 4: e7125
2. Collado MC, Isolauri E, Laitinen K, Salminen S. 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88: 894-899
3. Delzenne NM, Neyrinck AM, Cani PD. 2013. Gut microbiota and metabolic disorders: how prebiotic can work? Br J Nutr 109: S81-S85
4. Finegold SM, Li Z, Summanen PH, Downes J, Thames G, Corbett K, Dowd S, et al. 2014. Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food Funct 5: 436-445
5. Jousimies-Somer HR, Summanen P, Citron D, Baron E, Wexler HM, Finegold SM. 2002. Wadsworth-KTL anaerobic bacteriology manual. Belmont: Star Publishing
6. Kalliomaki M, Collado MC, Salminen S, Isolauri E. 2008. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87: 534-538
7. Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, Yaeshima T, et al. 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 74: 1656-1661
8. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023
9. Lonnermark E, Nowrouzinan F, Adlerberth I, Ahrne S, Wold A, Friman V. 2012. Oral and faecal lactobacilli and their expression of mannose-specific adhesins in individuals with and without IgA deficiency. Int J Med Microbiol 302: 53-60
10. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K. 2009. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 75: 1961-1969
11. Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, et al. 2012. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes 36: 817-825
12. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195
13. Slavin J. 2013. Fiber and prebiotics: mechanisms and health benefits. Nutrients 5: 1417-1435
14. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457: 480-484